Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study-Reference-Cited by-同舟云学术

Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study

Published:2023-06-20 Issue:1 Volume:53 Page:21-28
ISSN:0300-9742
Container-title:Scandinavian Journal of Rheumatology
language:en
Short-container-title:Scandinavian Journal of Rheumatology

Author:

Stisen ZR¹^ORCID,Nielsen SM¹²^ORCID,Ditlev SB³^ORCID,Skougaard M¹³⁴^ORCID,Egeberg A⁵⁶^ORCID,Mogensen M⁵⁶^ORCID,Jørgensen TS¹^ORCID,Dreyer L⁷^ORCID,Christensen R¹²^ORCID,Kristensen LE¹^ORCID

Affiliation:

1. The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark

2. Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark

3. Copenhagen Center for Translational Research, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

4. Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark

5. Department of Dermatology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

6. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

7. Center of Rheumatic Research Aalborg (CERRA), Department of Rheumatology, Aalborg University Hospital, Aalborg University, Aalborg, Denmark

Funder

the Danish Rheumatism Association, Danish Psoriasis Association

Oak Foundation

Minister Erna Hamiltons Legat for Videnskab og Kunst

Publisher

Informa UK Limited

Subject

Immunology,General Medicine,Immunology and Allergy,Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03009742.2023.2216046

Reference27 articles.

1. Psoriatic arthritis: epidemiology, clinical features, course, and outcome;Gladman DD;Ann Rheum Dis,2005

2. The pathogenesis of psoriatic arthritis

3. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population

4. Adipokines: New Potential Therapeutic Target for Obesity and Metabolic, Rheumatic, and Cardiovascular Diseases

5. Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study